Mesenchymal Stem Cells - Advances & Applications 2013

News provided by

Nov 21, 2013, 06:04 ET

DUBLIN, Ireland, November 21, 2013 /PRNewswire/ --

Research and Markets
( http://www.researchandmarkets.com/research/l9ff49/mesenchymal_stem) has announced the addition of the "Mesenchymal Stem Cells - Advances & Applications 2013" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

Understand and profit from the mesenchymal stem cell (MSC) product market - the fastest growing area of stem cell research.

Updated to reflect the most current trends and including five year market projections, this report focuses on the advances in MSC research. In 125 pages you'll explore research priorities by market segment, highlight individual labs and end-users of MSC products, understand the competitive environment for such products and discover market-leading trend analysis.

Revealing Unique Strategic Opportunities & Unknown Competitive Advantages

MSCs are advantageous over other stem cells types for several reasons. First, they avoid the ethical issues that surround embryonic stem cell research. Second, repeated studies have found that human MSCs are immuno-privileged, and therefore, represent an advantageous cell type for allogenic transplantation, reducing the risks of rejection and complications of transplantation. Recently, there have also been significant advances in the use of autologous MSCs to regenerate human tissues, including cartilage and meniscus, tendons, and bone fractures.

This market research report focuses on recent advances in MSC research applications, explores research priorities by market segment, highlights individual labs and end-users of MSC research products, explores the competitive environment for MSC research products, and provides 5-year growth and trend analysis. The report advantageously positions companies that wish to offer competitive stem cells products to this rapidly growing, well-funded research community.

Expanded and Updated Market Intelligence

This is an expanded and updated market intelligence report that includes:

- Updated Charts, Timelines, Metrics and Financials

- 5-Year Projection Data through 2016

- Expanded Competitive Environment Analysis

- Detailed Characterization of the Market, Emphasizing Statistical Trends

- Exploration of Recent Product Evolution and Projected Directions for Development

- Overview of Therapeutic Progress and Insight into Future Applications

- Detailed Evaluation of Profit Opportunities

- New Section on End-User Needs & Technical Preferences (Scientist Survey!)

Companies Mentioned:

- Abcam
- BD Biosciences
- Cell Applications
- Celprogen
- Cyagen Biosciences (China only)
- Genlantis
- Invitrogen
- LGC Standards/ATCC
- Lonza
- Millipore
- Miltenyi Biotec
- PAA - The Cell Culture Company
- PromoCell
- R&D Systems
- SA Biosciences
- ScienCell Research Laboratories
- STEMCELL Technologies Inc
- Thermo Scientific
- Trevigen, Inc.

For more information visit http://www.researchandmarkets.com/research/l9ff49/mesenchymal_stem

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology

SOURCE Research and Markets